These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 25572093)

  • 21. In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.
    Martín A; Vázquez-Villoldo N; Gómez-Vallejo V; Padro D; Soria FN; Szczupak B; Plaza-García S; Arrieta A; Reese T; Llop J; Domercq M; Matute C
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1124-38. PubMed ID: 26659901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis.
    Liu H; Jin H; Yue X; Luo Z; Liu C; Rosenberg AJ; Tu Z
    Mol Imaging Biol; 2016 Oct; 18(5):724-32. PubMed ID: 26975859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis.
    Elo P; Tadayon S; Liljenbäck H; Teuho J; Käkelä M; Koskensalo K; Saunavaara V; Virta J; Veres TZ; Kiviniemi A; Saraste A; Marjamäki P; Airas L; Jalkanen S; Roivainen A
    J Neuroinflammation; 2018 May; 15(1):128. PubMed ID: 29716612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Preventive and Curative Fingolimod Treatment Regimens on Microglia Activation and Disease Progression in a Rat Model of Multiple Sclerosis.
    Vállez García D; Doorduin J; de Paula Faria D; Dierckx RAJO; de Vries EFJ
    J Neuroimmune Pharmacol; 2017 Sep; 12(3):521-530. PubMed ID: 28361437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study.
    Brendel M; Probst F; Jaworska A; Overhoff F; Korzhova V; Albert NL; Beck R; Lindner S; Gildehaus FJ; Baumann K; Bartenstein P; Kleinberger G; Haass C; Herms J; Rominger A
    J Nucl Med; 2016 Jun; 57(6):954-60. PubMed ID: 26912428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal Imaging of T Cells and Inflammatory Demyelination in a Preclinical Model of Multiple Sclerosis Using
    Guglielmetti C; Levi J; Huynh TL; Tiret B; Blecha J; Tang R; VanBrocklin H; Chaumeil MM
    J Nucl Med; 2022 Jan; 63(1):140-146. PubMed ID: 33837066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis.
    Bail K; Notz Q; Rovituso DM; Schampel A; Wunsch M; Koeniger T; Schropp V; Bharti R; Scholz CJ; Foerstner KU; Kleinschnitz C; Kuerten S
    J Neuroinflammation; 2017 Jul; 14(1):148. PubMed ID: 28738885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
    Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S
    Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oral fingolimod in multiple sclerosis: therapeutic modulation of the sphingosine-1-phosphate system].
    Aktas O; Ingwersen J; Kieseier B; Küry P; Hohlfeld R; Hartung HP
    Nervenarzt; 2011 Feb; 82(2):215-25. PubMed ID: 20842337
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Chen BY; Ghezzi C; Villegas B; Quon A; Radu CG; Witte ON; Clark PM
    J Nucl Med; 2020 May; 61(5):757-763. PubMed ID: 31653711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis.
    Foster CA; Howard LM; Schweitzer A; Persohn E; Hiestand PC; Balatoni B; Reuschel R; Beerli C; Schwartz M; Billich A
    J Pharmacol Exp Ther; 2007 Nov; 323(2):469-75. PubMed ID: 17682127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a novel acetamidobenzoxazolone-based PET ligand for translocator protein (18 kDa) imaging of neuroinflammation in the brain.
    Tiwari AK; Yui J; Fujinaga M; Kumata K; Shimoda Y; Yamasaki T; Xie L; Hatori A; Maeda J; Nengaki N; Zhang MR
    J Neurochem; 2014 May; 129(4):712-20. PubMed ID: 24484439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis.
    Rossi S; Lo Giudice T; De Chiara V; Musella A; Studer V; Motta C; Bernardi G; Martino G; Furlan R; Martorana A; Centonze D
    Br J Pharmacol; 2012 Feb; 165(4):861-9. PubMed ID: 21740406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis].
    Chiba K; Yoshii N
    Nihon Yakurigaku Zasshi; 2012 Jun; 139(6):265-74. PubMed ID: 22728990
    [No Abstract]   [Full Text] [Related]  

  • 35. In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET.
    Colasanti A; Guo Q; Muhlert N; Giannetti P; Onega M; Newbould RD; Ciccarelli O; Rison S; Thomas C; Nicholas R; Muraro PA; Malik O; Owen DR; Piccini P; Gunn RN; Rabiner EA; Matthews PM
    J Nucl Med; 2014 Jul; 55(7):1112-8. PubMed ID: 24904112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Evaluation of Three TSPO PET Radiotracers in a LPS-Induced Model of Mild Neuroinflammation in Rats.
    Sridharan S; Lepelletier FX; Trigg W; Banister S; Reekie T; Kassiou M; Gerhard A; Hinz R; Boutin H
    Mol Imaging Biol; 2017 Feb; 19(1):77-89. PubMed ID: 27481358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fingolimod ameliorates the development of experimental autoimmune encephalomyelitis by inhibiting Akt-mTOR axis in mice.
    Hou H; Cao R; Miao J; Sun Y; Liu X; Song X; Guo L
    Int Immunopharmacol; 2016 Jan; 30():171-178. PubMed ID: 26632437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG PET detects inflammatory infiltrates in spinal cord experimental autoimmune encephalomyelitis lesions.
    Buck D; Förschler A; Lapa C; Schuster T; Vollmar P; Korn T; Nessler S; Stadelmann C; Drzezga A; Buck AK; Wester HJ; Zimmer C; Krause BJ; Hemmer B
    J Nucl Med; 2012 Aug; 53(8):1269-76. PubMed ID: 22738927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain inflammation in a chronic epilepsy model: Evolving pattern of the translocator protein during epileptogenesis.
    Amhaoul H; Hamaide J; Bertoglio D; Reichel SN; Verhaeghe J; Geerts E; Van Dam D; De Deyn PP; Kumar-Singh S; Katsifis A; Van Der Linden A; Staelens S; Dedeurwaerdere S
    Neurobiol Dis; 2015 Oct; 82():526-539. PubMed ID: 26388398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism].
    Tar L; Vécsei L
    Ideggyogy Sz; 2012 Mar; 65(3-4):83-100. PubMed ID: 23136726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.